Intestinal Candidiasis Support Protocol

Intestinal candidiasis refers to overgrowth of Candida yeast in the gut. While Candida is normally present in small amounts, various factors can allow it to overgrow, potentially causing digestive symptoms.

IMPORTANT NOTE:

The concept of 'candida overgrowth syndrome' is controversial in mainstream medicine. True invasive candidiasis is a serious medical condition in immunocompromised patients. Mild yeast imbalance may occur but diagnosis is difficult.

POTENTIAL SYMPTOMS:

•Bloating and gas

•Diarrhea or constipation

•Fatigue

•Sugar cravings

•Brain fog

•Oral thrush (white coating on tongue)

RISK FACTORS:

•Recent antibiotic use

•High sugar/refined carbohydrate diet

•Diabetes or high blood sugar

•Weakened immune system

•Chronic stress

•Corticosteroid use

DIETARY APPROACHES:

•Reduce refined sugars and carbohydrates

•Limit alcohol (especially beer and wine)

•Increase fiber intake

•Include fermented foods (unsweetened)

•Adequate protein

WHEN TO SEE A DOCTOR:

•Oral thrush or genital yeast infections

•Symptoms not improving with dietary changes

•Immunocompromised status

•Fever or severe symptoms

* Probiotics are foundational for restoring gut balance.

* S. boulardii is a beneficial yeast that competes with Candida.

* Natural antifungals may provide supportive benefit.

Expected timeline: Dietary changes and probiotics may improve symptoms within 2-4 weeks. Persistent symptoms require medical evaluation.

Clinical Perspective

Intestinal Candidiasis: Candida is commensal organism; true invasive candidiasis occurs in immunocompromised. 'Candida overgrowth syndrome' is not well-established diagnosis. GI Candida may contribute to symptoms in some patients post-antibiotics or with dysbiosis. Diagnosis challenging - stool cultures not reliable.

Clinical approach: Rule out other GI pathology. If pursuing anti-candida approach: dietary modification (reduce simple sugars), probiotics (Saccharomyces boulardii has best evidence), consider natural antifungals. Antifungal medications (fluconazole, nystatin) for documented infection. Most important: address underlying factors (diabetes control, judicious antibiotic use, immune status).

* S. boulardii (B-grade): Beneficial yeast. Systematic review: (PMID: 20145608). 250-500mg BID.

* Lactobacillus Probiotics (B-grade): Microbiome restoration. Review: (PMID: 24045160). 10-50B CFU daily.

* Caprylic Acid (C-grade): Antifungal MCFA. Studies: (PMID: 21830350). 500-1000mg TID.

* Oregano Oil (C-grade): Carvacrol/thymol. Review: (PMID: 22132098). 150-200mg BID.

* Garlic (C-grade): Allicin antifungal. Systematic review: (PMID: 24748799). 600-900mg daily.

* Berberine (C-grade): Antimicrobial alkaloid. Review: (PMID: 27822924). 500mg BID-TID.

Assessment targets: Symptom improvement, stool testing if indicated, oral/genital yeast examination.

Protocol notes: Diagnosis: stool cultures not reliable; diagnosis largely clinical. Diet: reduce simple carbs/sugars; increase fiber; fermented foods (unsweetened yogurt, kefir). Probiotics: S. boulardii especially useful; multi-strain lactobacillus. Die-off: some experience temporary worsening (Herxheimer-like); go slowly. Duration: 4-8 weeks typical trial. Antifungal rotation: some practitioners rotate natural antifungals weekly. Underlying factors: optimize blood sugar, minimize unnecessary antibiotics. When to refer: persistent symptoms, immunocompromised, systemic symptoms. Invasive candidiasis: medical emergency in immunocompromised; requires systemic antifungals. SIFO (Small Intestinal Fungal Overgrowth): emerging concept; may overlap with SIBO.

View All Protocols